Table 1.
Type of modification |
Organism | Gene(s) | Nuclease(s) | Ref(s) |
---|---|---|---|---|
Gene disruption | Human | CCR5 | ZFN | [66, 92, 93] |
TALEN | [26, 53] | |||
CRISPR/Cas | [102] | |||
Human | TCR (T-cell receptor) | ZFN | [95, 96] | |
Zebrafish |
gol (Golden), ntl (No tail), kra |
ZFN | [67, 69] | |
Pig |
GGTA1 (α1, 3- galactosyltransferase) |
ZFN | [78] | |
LDLR (LDL receptor) | TALEN | [77] | ||
Bovine | ACAN12, p65 | TALEN | [77] | |
Human | EMX1, PVALB | CRISPR/Cas | [103] | |
Rat | IgM, Rab38 | ZFN | [71] | |
Arabidopsis | ADH1, TT4 | ZFN | [82] | |
C. elegans | ben-1, rex-1, sdc-2 | ZFN/TALEN | [79] | |
Hamster | DHFR | ZFN | [38] | |
Drosophila | yellow | ZFN | [73] | |
Rice | OsSWEET14 | TALEN | [85] | |
Gene addition | Human | OCT4, PITX3 | ZFN/TALEN | [46, 47] |
Human | CCR5 | ZFN | [98] | |
Human |
F9 (Coagulation Factor IX) |
ZFN | [87] | |
Mouse | Rosa26 | ZFN | [58] | |
Human | AAVS1 | ZFN | [46, 97, 98] | |
TALEN | [47] | |||
CRISPR/Cas | [104] | |||
Human | VEGF-A | ZFN | [18] | |
Zebrafish |
th (tyrosine hydroxylase), fam46c smad5 |
TALEN | [81] | |
Maize | IPK1 | ZFN | [83] | |
Gene correction | Human | IL2RG | ZFN | [45, 86] |
A1AT (α1-antitrypsin) | ZFN | [90] | ||
HBB (β-globin) | ZFN | [88, 89] | ||
SNCA (α-synuclein) | ZFN | [91] | ||
Tobacco |
SuRA, SurRB (acetolactate synthase) |
ZFN | [84] | |
Drosophila | yellow | ZFN | [72] |